Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial.

Cancers (Basel) · 2025 · PMC12384391 · PMID 40867307

Europe PMC DOI

hedged sentence

0.0712

closest p · 1.4× alpha

0.0712

boldest claim

The sentences

did not reach statistical significancep = 0.0712so close (0.05 < p ≤ 0.1)

Despite a 16-point rise, the global health status scale did not reach statistical significance ( p = 0.0712), likely owing to sample attrition and baseline heterogeneity; by contrast, improvements in daily (+24.7), cognitive (+17.5), and social (+25.1) functions exceeded the 10-point threshold for clinical relevance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.